{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:32:32Z","timestamp":1790872352823,"version":"4.1.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Accumulation of somatic hematopoietic stem cell mutations with aging has been revealed by the recent genome-wide analysis. Clonal expansion, known as clonal hematopoiesis of indeterminate potential (CHIP), is a premalignant condition of hematological cancers. It is defined as the absence of definitive morphological evidence of a hematological neoplasm and occurrence of \u22652% of mutant allele fraction in the peripheral blood. In CHIP, the most frequently mutated genes are epigenetic regulators such as <jats:italic>DNMT3A, TET2,<\/jats:italic> and <jats:italic>ASXL1.<\/jats:italic> CHIP induces inflammation. CHIP is shown to be associated with not only hematological malignancy but also non-malignant disorders such as atherosclerosis, cardiovascular diseases and chronic liver disease. In addition, recent several large clinical trials have shown that CHIP is also the risk factor for developing chronic kidney disease (CKD). In this review article, we proposed novel findings about CHIP and CHIP related kidney disease based on the recent basic and clinical research. The possible mechanism of the kidney injury in CHIP is supposed to be due to the clonal expansion in both myeloid and lymphoid cell lines. In myeloid cell lines, the mutated macrophages increase the inflammatory cytokine level and induce chronic inflammation. It leads to epigenetic downregulation of kidney and macrophage klotho level. In lymphoid cell lines, CHIP might be related to monoclonal gammopathy of renal significance (MGRS). It describes any B cell or plasma cell clonal disorder that does not fulfill the criteria for cancer yet produces a nephrotoxic monoclonal immunoglobulin that leads to kidney injury or disease. MGRS causes M-protein related nephropathy frequently observed among aged CKD patients. It is important to consider the CHIP-related complications such as hematological malignancy, cardiovascular diseases and metabolic disorders in managing the elderly CKD patients. There are no established therapies for CHIP and CHIP-related CKD yet. However, recent studies have supported the development of effective CHIP therapies, such as blocking the expansion of aberrant HSCs and inhibiting chronic inflammation. In addition, drugs targeting the epigenetic regulation of Klotho in the kidney and macrophages might be therapeutic targets of CHIP in the kidney.<\/jats:p>","DOI":"10.3389\/fcell.2023.1281850","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:04:39Z","timestamp":1697785479000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Epigenetic roles in clonal hematopoiesis and aging kidney-related chronic kidney disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Yoshiyasu","family":"Ogura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imari","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","article-title":"Adipocyte accumulation in the bone marrow during obesity and aging impairs stem cell-based hematopoietic and bone regeneration","volume":"20","author":"Ambrosi","year":"2017","journal-title":"Cell. Stem Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00018-019-03084-7","article-title":"The role of ASXL1 in hematopoiesis and myeloid malignancies","volume":"76","author":"Asada","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1038\/ncomms8307","article-title":"Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex","volume":"6","author":"Balasubramani","year":"2015","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41420-021-00528-7","article-title":"DNA demethylase Tet2 suppresses cisplatin-induced acute kidney injury","volume":"7","author":"Bao","year":"2021","journal-title":"Cell. Death Discov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-023-02397-2","article-title":"Clonal hematopoiesis is associated with protection from Alzheimer's disease","volume":"29","author":"Bouzid","year":"2023","journal-title":"Nat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ki.2014.408","article-title":"Diagnosis of monoclonal gammopathy of renal significance","volume":"87","author":"Bridoux","year":"2015","journal-title":"Kidney Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fendo.2020.00560","article-title":"Klotho, aging, and the failing kidney","volume":"11","author":"Buchanan","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2018-01-829937","article-title":"Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A","volume":"132","author":"Buscarlet","year":"2018","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell. Stem Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111254","DOI":"10.1016\/j.mce.2021.111254","article-title":"Renin-angiotensin system and inflammation update","volume":"529","author":"Cantero-Navarro","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/leu.2009.141","article-title":"Mutations of ASXL1 gene in myeloproliferative neoplasms","volume":"23","author":"Carbuccia","year":"2009","journal-title":"Leukemia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1182\/blood.2020006510","article-title":"Clonal hematopoiesis: mechanisms driving dominance of stem cell clones","volume":"136","author":"Challen","year":"2020","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.1009","article-title":"Dnmt3a is essential for hematopoietic stem cell differentiation","volume":"44","author":"Challen","year":"2011","journal-title":"Nat. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e79856","DOI":"10.1371\/journal.pone.0079856","article-title":"Elevated Klotho promoter methylation is associated with severity of chronic kidney disease","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy","volume":"75","author":"Chevalier","year":"2009","journal-title":"Kidney Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell."},{"key":"B22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell. Stem Cell."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1073\/pnas.1703476114","article-title":"Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement","volume":"114","author":"Dai","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41375-021-01382-3","article-title":"Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease","volume":"36","author":"Dawoud","year":"2022","journal-title":"Leukemia"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","article-title":"Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking","volume":"34","author":"Dawoud","year":"2020","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ekir.2022.01.1064","article-title":"Clonal hematopoiesis of indeterminate potential and diabetic kidney disease: a nested case-control study","volume":"7","author":"Denicolo","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1200\/JCO.2008.17.7865","article-title":"Update on treatment recommendations from the fourth international workshop on waldenstrom's macroglobulinemia","volume":"27","author":"Dimopoulos","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mce.2016.05.008","article-title":"Update on FGF23 and klotho signaling","volume":"432","author":"Erben","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-021-22053-y","article-title":"Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt\/mTOR pathway","volume":"12","author":"Fujino","year":"2021","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.exphem.2020.01.002","article-title":"ASXL1 mutation in clonal hematopoiesis","volume":"83","author":"Fujino","year":"2020","journal-title":"Exp. Hematol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"108326","DOI":"10.1016\/j.celrep.2020.108326","article-title":"TET2-Loss-of-Function-Driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity","volume":"33","author":"Fuster","year":"2020","journal-title":"Cell. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1681\/ASN.2019080797","article-title":"Dnmt3a and dnmt3b-decommissioned fetal enhancers are linked to kidney disease","volume":"31","author":"Guan","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","article-title":"Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms","volume":"128","author":"Hinds","year":"2016","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ng.868","article-title":"De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome","volume":"43","author":"Hoischen","year":"2011","journal-title":"Nat. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","article-title":"Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN\u03b3 signaling","volume":"28","author":"Hormaechea-Agulla","year":"2021","journal-title":"Cell. Stem Cell."},{"key":"B40","doi-asserted-by":"publisher","first-page":"110352","DOI":"10.1016\/j.cellsig.2022.110352","article-title":"DNMT3a negatively regulates PTEN to activate the PI3K\/AKT pathway to aggravate renal fibrosis","volume":"96","author":"Hu","year":"2022","journal-title":"Cell. Signal"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1210\/jc.2018-02076","article-title":"Epigenetic age acceleration in adolescence associates with BMI, inflammation, and risk score for middle age cardiovascular disease","volume":"104","author":"Huang","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-physiol-022516-034219","article-title":"Macrophages in renal injury and repair","volume":"79","author":"Huen","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41375-020-0795-z","article-title":"Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study","volume":"34","author":"Husby","year":"2020","journal-title":"Leukemia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ki.2015.291","article-title":"Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression","volume":"89","author":"Irifuku","year":"2016","journal-title":"Kidney Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"iv6","DOI":"10.1093\/ndt\/gfs426","article-title":"Klotho, phosphate and inflammation\/ageing in chronic kidney disease","volume":"27","author":"Izquierdo","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"B46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann. Intern Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/blood.2019000989","article-title":"Clonal hematopoiesis and nonhematologic disorders","volume":"136","author":"Jaiswal","year":"2020","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ymthe.2019.05.019","article-title":"Extracellular vesicles from albumin-induced tubular epithelial cells promote the M1 macrophage phenotype by targeting klotho","volume":"27","author":"Jia","year":"2019","journal-title":"Mol. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-9967-2_1","article-title":"DNA methyltransferases, DNA damage repair, and cancer","volume":"754","author":"Jin","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/cells12121581","article-title":"The role of inflammation in CKD","volume":"12","author":"Kadatane","year":"2023","journal-title":"Cells"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","article-title":"Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nat. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/j.ajkd.2022.08.014","article-title":"Clonal hematopoiesis of indeterminate potential and kidney function decline in the general population","volume":"81","author":"Kestenbaum","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-O","year":"1997","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","article-title":"Population dynamics of normal human blood inferred from somatic mutations","volume":"561","author":"Lee-Six","year":"2018","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal gammopathy of renal significance","volume":"384","author":"Leung","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"856088","DOI":"10.3389\/fphys.2022.856088","article-title":"CCL5 suppresses klotho expression via p-STAT3\/DNA methyltransferase1-mediated promoter hypermethylation","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ymthe.2019.02.009","article-title":"MicroRNA-34a promotes renal fibrosis by downregulation of klotho in tubular epithelial cells","volume":"27","author":"Liu","year":"2019","journal-title":"Mol. Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front. Biosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbrc.2015.09.077","article-title":"Role of Asxl1 in kidney podocyte development via its interaction with Wtip","volume":"466","author":"Moon","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1681\/ASN.2010101073","article-title":"The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB","volume":"22","author":"Moreno","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0218468","DOI":"10.1371\/journal.pone.0218468","article-title":"microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress","volume":"14","author":"Morii","year":"2019","journal-title":"PLoS One"},{"key":"B71","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41590-020-0663-z","article-title":"Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs","volume":"21","author":"Muto","year":"2020","journal-title":"Nat. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e13366","DOI":"10.1111\/acel.13366","article-title":"Clonal hematopoiesis associated with epigenetic aging and clinical outcomes","volume":"20","author":"Nachun","year":"2021","journal-title":"Aging Cell."},{"key":"B73","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000476078","article-title":"Epigenetic changes in the acute kidney injury-to-chronic kidney disease transition","volume":"137","author":"Nangaku","year":"2017","journal-title":"Nephron"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","article-title":"Distinction of lymphoid and myeloid clonal hematopoiesis","volume":"27","author":"Niroula","year":"2021","journal-title":"Nat. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.celrep.2018.11.014","article-title":"Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis","volume":"25","author":"Osorio","year":"2018","journal-title":"Cell. Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1182\/blood.2020006913","article-title":"Management of AL amyloidosis in 2020","volume":"136","author":"Palladini","year":"2020","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/039463201002300311","article-title":"Identification of IP-10 and IL-5 as proteins differentially expressed in human complicated and uncomplicated carotid atherosclerotic plaques","volume":"23","author":"Profumo","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","first-page":"F1329","DOI":"10.1152\/ajprenal.00487.2016","article-title":"Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms","volume":"311","author":"Ruiz-Andres","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/ndt\/gfy291","article-title":"AL amyloidosis: advances in diagnostics and treatment","volume":"34","author":"Rysava","year":"2019","journal-title":"Nephrol. Dial. Transpl."},{"key":"B83","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1172\/JCI115629","article-title":"Pathobiology of cast nephropathy from human Bence Jones proteins","volume":"89","author":"Sanders","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B84","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"","journal-title":"Circ. Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-Mediated clonal hematopoiesis accelerates heart failure through a\u00a0Mechanism involving the IL-1\u03b2\/NLRP3\u00a0Inflammasome","volume":"71","author":"Sano","year":"","journal-title":"J. Am. Coll. Cardiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/leu.2013.337","article-title":"The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases","volume":"28","author":"Solary","year":"2014","journal-title":"Leukemia"},{"key":"B87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"B88","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"B89","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1182\/blood-2015-02-585059","article-title":"Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification","volume":"126","author":"Strati","year":"2015","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.ackd.2022.01.004","article-title":"Monoclonal gammopathy-related kidney diseases","volume":"29","author":"Sy-Go","year":"2022","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/ph15020123","article-title":"Therapies targeting epigenetic alterations in acute kidney injury-to-chronic kidney disease transition","volume":"15","author":"Tanemoto","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1003227","DOI":"10.3389\/fmolb.2022.1003227","article-title":"Epigenetic memory contributing to the pathogenesis of AKI-to-CKD transition","volume":"9","author":"Tanemoto","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/CS20180465","article-title":"Histone acetylation and DNA methylation in ischemia\/reperfusion injury","volume":"133","author":"Tang","year":"2019","journal-title":"Clin. Sci. (Lond)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1053\/j.seminoncol.2022.11.001","article-title":"Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias","volume":"49","author":"Testa","year":"2022","journal-title":"Semin. Oncol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","article-title":"Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged \u226580 years","volume":"5","author":"Van Zeventer","year":"2021","journal-title":"Blood Adv."},{"key":"B97","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1681\/ASN.2021060774","article-title":"Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease","volume":"33","author":"Vlasschaert","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.stem.2021.01.011","article-title":"Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets","volume":"28","author":"Wang","year":"2021","journal-title":"Cell. Stem Cell."},{"key":"B99","doi-asserted-by":"publisher","first-page":"10822","DOI":"10.3390\/ijms221910822","article-title":"Inflammation and oxidative stress in diabetic kidney disease: the targets for SGLT2 inhibitors and GLP-1 receptor agonists","volume":"22","author":"Winiarska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1681\/ASN.2014040392","article-title":"In search of the fountain of youth","volume":"25","author":"Wolf","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-023-05857-4","article-title":"Clonal haematopoiesis and risk of chronic liver disease","volume":"616","author":"Wong","year":"2023","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","first-page":"E157","DOI":"10.1002\/ajh.26125","article-title":"Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy","volume":"96","author":"Wudhikarn","year":"2021","journal-title":"Am. J. Hematol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"B104","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00109-021-02044-8","article-title":"Epigenetic modifications of Klotho expression in kidney diseases","volume":"99","author":"Xia","year":"2021","journal-title":"J. Mol. Med. Berl."},{"key":"B105","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1210\/er.2013-1079","article-title":"Molecular basis of Klotho: from gene to function in aging","volume":"36","author":"Xu","year":"2015","journal-title":"Endocr. Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"43592","DOI":"10.1038\/srep43592","article-title":"Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patients","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.lfs.2018.04.044","article-title":"Effect of TET2 on the pathogenesis of diabetic nephropathy through activation of transforming growth factor \u03b21 expression via DNA demethylation","volume":"207","author":"Yang","year":"2018","journal-title":"Life Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1038\/s41598-017-05564-x","article-title":"Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation","volume":"7","author":"Youn","year":"2017","journal-title":"Sci. Rep."},{"key":"B109","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","article-title":"Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2217\/epi-2022-0430","article-title":"Low-dose 5-aza-2'-deoxycytidine protects against early renal injury by increasing klotho expression","volume":"14","author":"Zhao","year":"2022","journal-title":"Epigenomics"},{"key":"B111","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1281850\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:04:42Z","timestamp":1697785482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1281850\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":107,"alternative-id":["10.3389\/fcell.2023.1281850"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1281850","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"article-number":"1281850"}}